Curi Bio is accelerating the discovery of the next generation of medicines by integrating human cells, systems, and data.
Location: United States, Washington, Seattle
Employees: 11-50
Phone: +1 800-913-4403
Total raised: $16M
Founded date: 2015
Investors 1
Date | Name | Website |
- | UTC Invest... | utc.co.kr |
Funding Rounds 2
Date | Series | Amount | Investors |
03.01.2022 | Series A | $10M | - |
18.03.2021 | Series A | $6M | - |
Mentions in press and media 14
Date | Title | Description | Source |
15.02.2023 | Tech Moves: T-Mobile tech leader to retire; Curi Bio and Cro... | Elizabeth Liu. (Crowd Cow Photo) — Joe Heitzeberg is stepping down as CEO of CrowdCow, the Seattle-... | geekwire.c... |
02.06.2022 | A Scalable System to Engineer Human 3D Muscle Tissues for Dr... | Guest speaker Dr. Chris Hinckley from Biogen, will present some of Biogen’s recent data generated us... | prweb.com/... |
03.01.2022 | Curi Bio scores $10M for stem cell-focused drug discovery pl... | Photo: Longhua Liao/Getty Images Seattle-based startup Curi Bio landed $10 million in Series A fund... | mobihealth... |
03.01.2022 | Curi Bio lands $10M Series A | Curi Bio has raised $10 million from investors including Dynamk Capital and DS Asset Management. Bas... | pitchbook.... |
03.01.2022 | Curi Bio Closes $10M Series A Funding Round | Curi Bio Inc., a Seattle, WA-based developer of human stem cell-based platforms for drug discovery, ... | finsmes.co... |
30.12.2021 | Curi Bio Closes $10M Oversubscribed Series A | SEATTLE, WA, Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, ... | vcnewsdail... |
29.12.2021 | Curi Bio Closes $10Million Series A In Oversubscribed Round | With New Funding Curi Bio will Advance 3D Engineered Muscle Tissue Products for Drug Discovery Curi... | aithority.... |
29.12.2021 | Curi Bio Closes $10M Series A in Oversubscribed Round | Curi Bio Inc., a leading developer of human stem cell-based platforms for drug discovery, announced ... | marketscre... |
19.03.2021 | Curi Bio Raises $6M in Series A Financing | Curi Bio Inc., a Seattle, WA-based developer of human stem cell-based platforms for drug discovery, ... | finsmes.co... |
19.03.2021 | Seattle stem cell startup Curi Bio raises $6M | Curi Bio Chief Business Officer Elliot Fisher and CEO Michael Cho. (Curi Bio Photos) New funding: C... | geekwire.c... |
Show more